SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Equities researchers at Raymond James lifted their Q3 2025 EPS estimates for SNC-Lavalin Group in a report released on Wednesday, February 19th. Raymond James analyst F. Bastien now anticipates that the company will post earnings of $0.79 per share for the quarter, up from their prior estimate of $0.77. Raymond James also issued estimates for SNC-Lavalin Group’s Q4 2025 earnings at $0.81 EPS, FY2025 earnings at $2.85 EPS, Q1 2026 earnings at $0.72 EPS, Q3 2026 earnings at $0.98 EPS, Q4 2026 earnings at $0.82 EPS and FY2026 earnings at $3.40 EPS.
Separately, Stifel Canada upgraded SNC-Lavalin Group to a “strong-buy” rating in a report on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
About SNC-Lavalin Group
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Read More
- Five stocks we like better than SNC-Lavalin Group
- How to Effectively Use the MarketBeat Ratings Screener
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Where Do I Find 52-Week Highs and Lows?
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Growth Stocks: What They Are, Examples and How to Invest
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
